Eiger BioPharmaceuticals, Inc.

EIGRDelisted Apr 25, 2024

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001305253

SEC filings (opens in a new tab)

Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.

Superinvestors holding EIGR, Q4 2023

See all superinvestors

No superinvestor reported holding EIGR in Q4 2023.